NextCure
-$0.01 (-0.28%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NextCure and other ETFs, options, and stocks.
About NXTC
NextCure, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing immunomedicines to treat cancer and other immune-related diseases. Its novel FIND-IO discovery technology identifies targets based on immunomodulatory function and on which the company is building a proprietary pipeline of immunomedicines.
CEO
Michael S. Richman
Employees
87
Headquarters
Beltsville, Maryland
Founded
2015
NXTC Key Statistics
Market cap
97.95M
Price-Earnings ratio
—
Dividend yield
—
Average volume
127.98K
High today
$3.63
Low today
$3.47
Open price
$3.53
Volume
102.26K
52 Week high
$9.18
52 Week low
$3.25
Analyst ratings
57%
of 7 ratings
Buy
57.1%
Hold
28.6%
Sell
14.3%
NXTC Earnings
-$0.74
-$0.49
-$0.25
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, After Hours